{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:14:50Z","timestamp":1789971290804,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"crossref","award":["15-14-00048"],"award-info":[{"award-number":["15-14-00048"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.vaccine.2016.03.041","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T07:23:42Z","timestamp":1458631422000},"page":"2354-2361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin"],"prefix":"10.1016","volume":"34","author":[{"given":"L.L.","family":"Chernokhaeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu.V.","family":"Rogova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Vorovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.Iu.","family":"Romanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.I.","family":"Kozlovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B.","family":"Maikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3764-7081","authenticated-orcid":false,"given":"I.S.","family":"Kholodilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.G.","family":"Karganova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.03.041_bib0170","first-page":"45","article-title":"Studies on antigenic relationships among the viruses of the group B tick-borne complex","volume":"31","author":"Clarke","year":"1964","journal-title":"Bull World Health Organ"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2016.03.041_bib0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1099\/0022-1317-70-1-37","article-title":"Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera","volume":"70","author":"Calisher","year":"1989","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.03.041_bib0180","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2006.09.015","article-title":"Genetic characterization of tick-borne flaviviruses: new insights into evolution, pathogenetic determinants and taxonomy","volume":"361","author":"Grard","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.03.041_bib0185","series-title":"Virus taxonomy: ninth report f the international committee on taxonomy of viruses","author":"King","year":"2012"},{"key":"10.1016\/j.vaccine.2016.03.041_bib0190","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/jmv.21765","article-title":"Genotyping and characterization of the geographical distribution of tick-borne encephalitis virus variants with a set of molecular probes","volume":"82","author":"Demina","year":"2010","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2016.03.041_bib0195","first-page":"572","article-title":"The A\u012dna\/1448 serotype of the tick-borne encephalitis virus","volume":"30","author":"Bochkova","year":"1985","journal-title":"Vopr Virusol"},{"issue":"64","key":"10.1016\/j.vaccine.2016.03.041_bib0200","first-page":"14","article-title":"Genetic and Biological Properties of the Original Group of \u0422ick-Borne Encephalitis Virus Strains Circulating in Eastern Siberia","volume":"3","author":"Kozlova","year":"2012","journal-title":"Epidemiol Vaccin Prevent"},{"issue":"6","key":"10.1016\/j.vaccine.2016.03.041_bib0205","first-page":"24","article-title":"Comparative analysis of virulence of the Siberian and Far-East subtypes of the tick-born encephalitis virus","volume":"49","author":"Pogodina","year":"2004","journal-title":"Vopr Virusol"},{"key":"10.1016\/j.vaccine.2016.03.041_bib0210","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.vaccine.2011.12.013","article-title":"Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes","volume":"30","author":"Fritz","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.041_bib0215","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1186\/s40064-015-1561-y","article-title":"Genetic description of tick-borne encephalitis virus strain Sofjin with the longest history as a vaccine strain","volume":"4","author":"Vorovitch","year":"2015","journal-title":"SpringerPlus"},{"issue":"29","key":"10.1016\/j.vaccine.2016.03.041_bib0220","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.vaccine.2011.09.114","article-title":"Flaviviruses and flavivirus vaccines","volume":"30","author":"Heinz","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.041_bib0225","first-page":"116","article-title":"Massive immunization of the Sverdlovsk region population against tick-borne encephalitis, its epidemiological, clinical and immunological efficacy","volume":"23","author":"Romanenko","year":"2006","journal-title":"Med Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2016.03.041_bib0230","first-page":"22","article-title":"Experience in implementing the mass immunization program against tick-borne encephalitis in the Sverdlovsk region","volume":"52","author":"Romanenko","year":"2007","journal-title":"Vopr Virusol"},{"issue":"16","key":"10.1016\/j.vaccine.2016.03.041_bib0235","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1016\/j.vaccine.2010.02.001","article-title":"Vaccine failures after active immunisation against tick-borne encephalitis","volume":"28","author":"Andersson","year":"2010","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2016.03.041_bib0240","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.vaccine.2009.02.069","article-title":"Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human","volume":"27","author":"Leonova","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2016.03.041_bib0245","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/infdis\/jir122","article-title":"A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans","volume":"203","author":"Orlinger","year":"2011","journal-title":"J Infect Dis"},{"issue":"25","key":"10.1016\/j.vaccine.2016.03.041_bib0250","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1016\/j.vaccine.2014.02.046","article-title":"Evaluation of immune response and protective effect of four vaccines against the tick-borne ncephalitis virus","volume":"32","author":"Morozova","year":"2014","journal-title":"Vaccine"},{"issue":"78","key":"10.1016\/j.vaccine.2016.03.041_bib0255","first-page":"88","article-title":"Experimental studies cross immune response to antigens of the virus strains of tick-borne encephalitis different genotypes in BALB\/c mice, immunized with various embodiments of tick-borne encephalitis vaccine","volume":"5","author":"Afonina","year":"2014","journal-title":"Epidemiol Vaccin Prevent"},{"issue":"5","key":"10.1016\/j.vaccine.2016.03.041_bib0260","first-page":"221","article-title":"Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the \u201cImmuno\u201d firm","volume":"41","author":"Vorob\u2019eva","year":"1996","journal-title":"Vopr Virusol"},{"key":"10.1016\/j.vaccine.2016.03.041_bib0265","first-page":"35","article-title":"The relationship of the antigenic characteristics of the tick-borne encephalitis virus to the level of the protective activity of inactivated cultured vaccines","volume":"11\u201312","author":"Vorob\u2019eva","year":"1992","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"key":"10.1016\/j.vaccine.2016.03.041_bib0270","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0264-410X(92)90376-U","article-title":"Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypes","volume":"10","author":"Holzmann","year":"1992","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2016.03.041_bib0275","doi-asserted-by":"crossref","first-page":"e61094","DOI":"10.1371\/journal.pone.0061094","article-title":"Exploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy","volume":"8","author":"Pripuzova","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2016.03.041_bib0280","doi-asserted-by":"crossref","first-page":"e94946","DOI":"10.1371\/journal.pone.0094946","article-title":"The relationship between the structure of the tick-borne encephalitis virus strains and their pathogenic properties","volume":"9","author":"Belikov","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vaccine.2016.03.041_bib0285","first-page":"33","article-title":"Functional activity of specific antibodies in patients vaccinated against tick-borne encephalitis in relation to different virus strains","volume":"55","author":"Leonova","year":"2010","journal-title":"Vopr Virusol"},{"issue":"6","key":"10.1016\/j.vaccine.2016.03.041_bib0290","first-page":"89","article-title":"Immunological characteristics of the vaccination of human against tick-borne encephalitis with inactivated preparations differing in the concentration of the viral antigen","author":"Elbert","year":"1981","journal-title":"J Microbiol Epidemiol Immunobiol"},{"issue":"21","key":"10.1016\/j.vaccine.2016.03.041_bib0295","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","article-title":"ClustalW, Clustal X, version 2.0","volume":"23","author":"Larkin","year":"2007","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.vaccine.2016.03.041_bib0300","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2016.03.041_bib0305","series-title":"Laboratory techniques in rabies","first-page":"321","article-title":"Methods of calculation","author":"Lorenz","year":"1973"},{"issue":"3","key":"10.1016\/j.vaccine.2016.03.041_bib0310","first-page":"346","article-title":"Use of the fluorescent antibody method for study of the course of infection in the immune organism tick-borne encephalitis","volume":"9","author":"Shi-tsze","year":"1965","journal-title":"J Hyg Epidemiol Microbiol Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2016.03.041_bib0315","first-page":"31","article-title":"Prevention of tick-borne encephalitis: current aspects","volume":"52","author":"Lashkevich","year":"2007","journal-title":"Vopr Virusol"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2016.03.041_bib0320","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s10354-015-0362-9","article-title":"Tick-borne encephalitis (TBE) and TBE-vaccination in Austria: update 2014","volume":"165","author":"Kunze","year":"2015","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.vaccine.2016.03.041_bib0325","first-page":"110","article-title":"Structure of tick-borne encephalitis populations in the Sverdlovsk region nowadays and vaccine prevention questions","volume":"23","author":"Pogodina","year":"2006","journal-title":"Med Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.03.041_bib0330","doi-asserted-by":"crossref","DOI":"10.18821\/0507-4088-2016-61-3-135-139","article-title":"Vaccines based on Far-Eastern and European strains induce neutralizing antibodies against all known Tick-borne encephalitis viruses subtypes","volume":"61","author":"Maikova","year":"2016","journal-title":"Vopr Virusol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T21:44:33Z","timestamp":1655329473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1630024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":33,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0264410X1630024X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}